SPY326.52+2.56 0.79%
DIA264.35+1.07 0.41%
IXIC10,745.28+157.46 1.49%
News
IGMS
--
0.00%
--
2 Biotech Stocks That Could Soar in 2020
MotleyFool.com · 07/01 11:12
HC Wainwright & Co. Initiates Coverage On IGM Biosciences with Buy Rating, Announces Price Target of $88
HC Wainwright & Co. analyst Raghuram Selvaraju initiates coverage on IGM Biosciences (NASDAQ:IGMS) with a Buy rating and announces Price Target of $88.
Benzinga · 07/01 11:01
Stifel Maintains Buy on IGM Biosciences, Raises Price Target to $95
Stifel maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $67 to $95.
Benzinga · 06/30 13:30
Hedge Funds Getting Bullish On IGM Biosciences, Inc. (IGMS)
Insider Monkey · 06/28 22:58
The Daily Biotech Pulse: Chiasma, Heron Await FDA Decisions, DBV Restructures, 3 Biopharmas Make Wall Street Debuts
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 25)
Benzinga · 06/26 12:28
The Daily Biotech Pulse: Merck's Wonder Cancer Drug Snags Another Approval, Decision Day For Zogenix, UniQure Out-Licenses Gene Therapy
The following is a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech Stocks Hitting 52-week Highs June 24)
Benzinga · 06/25 12:26
IGM Biosciences, Inc. (NASDAQ:IGMS) Insiders Increased Their Holdings
Simply Wall St. · 06/16 11:27
IGM Biosciences to Present at the Jefferies 2020 Healthcare Conference
GlobeNewswire · 05/28 12:00
SunTrust Robinson Humphrey Initiates Coverage On IGM Biosciences with Buy Rating, Announces Price Target of $86
SunTrust Robinson Humphrey analyst Asthika Goonewardene initiates coverage on IGM Biosciences (NASDAQ:IGMS) with a Buy rating and announces Price Target of $86.
Benzinga · 05/28 11:24
IGM Biosciences (IGMS) Investor Presentation - Slideshow
Seeking Alpha - Article · 05/20 19:52
IGM Biosciences to Present at the 2020 RBC Capital Markets Global Healthcare Conference
GlobeNewswire · 05/12 12:00
Stifel Maintains Buy on IGM Biosciences, Raises Price Target to $67
Stifel maintains IGM Biosciences (NASDAQ:IGMS) with a Buy and raises the price target from $60 to $67.
Benzinga · 05/08 17:32
IGM Biosciences Announces First Quarter 2020 Financial Results and Provides Corporate Update
GlobeNewswire · 05/07 21:03
IGM Biosciences Q1 EPS $(0.580) Misses $(0.550) Estimate
IGM Biosciences (NASDAQ:IGMS) reported quarterly losses of $(0.580) per share which missed the analyst consensus estimate of $(0.550) by 5.45 percent.
Benzinga · 05/07 20:11
Was The Smart Money Right About IGM Biosciences, Inc. (IGMS)?
We hate to say this but, we told you so. On February 27th we published an article with the title Recession is Imminent: We Need A Travel Ban NOW and predicted a US recession when the S&P 500 Index was trading at the 3150 level. We also told you to short the ma
Insider Monkey · 05/07 16:25
Week In Review: I-Mab Seeking $2 Billion Deal For CD-47 Candidate
Seeking Alpha - Article · 05/04 07:19
Benzinga's Top Upgrades, Downgrades For April 22, 2020
Upgrades
Benzinga · 04/22 13:40
BofA likes Johnson & Johnson in premarket analyst action
Seeking Alpha - Article · 04/22 11:38
Wedbush Initiates Coverage On IGM Biosciences with Outperform Rating, Announces Price Target to $73
Wedbush analyst Robert Driscoll initiates coverage on IGM Biosciences (NASDAQ:IGMS) with a Outperform rating and announces Price Target to $73.
Benzinga · 04/22 08:56
3 Ultra-Risky Biotech Stocks That Could Make You Filthy Rich
MotleyFool.com · 04/21 11:57